# High Dose Omeprazole in Patients With Pancreatic Cancer

> **NCT04930991** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Oklahoma** · enrollment: 60 (estimated)

## Conditions studied

- Exocrine Pancreatic Cancer

## Interventions

- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT04930991
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-07
- **Primary completion:** 2026-09
- **Final completion:** 2027-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04930991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04930991, "High Dose Omeprazole in Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04930991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*